Search
Close this search box.
Search
Close this search box.

Vomaris Announces First Patient Enrollment in Study on Effects of Bioelectric Wound Care in Hidradenitis Suppurativa

Vomaris Innovations, Inc. announces the first patient enrollment in a study using its bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).   About HSHS is a chronic inflammatory skin condition that affects 1-4% of the global population. It occurs more often in women than men and is characterized by recurring pus-filled […]

Technology Effective Against Antibiotic-Resistant Pathogen

Research shows antibiotic-resistant Candida albicans is killed by exposure to Vomaris Bioelectric V.Dox™ Technology   Vomaris Innovations, Inc. announced today the publication of results demonstrating that the company’s bioelectric V.Dox™ Technology is effective in killing antibiotic-resistant Candida albicans pathogens. The manuscript, “Ketoconazole Resistant Candida albicans is Sensitive to a Wireless Electroceutical Wound Care Dressing,” was published in Bioelectrochemistry […]

Thank you for contacting Vomaris.
We will respond to you within 48 hours.

Skip to content